Evidence map›Paper›PMID 31160568›Full record

ArticleNature communications2019

A comprehensive single cell transcriptional landscape of human hematopoietic progenitors.

Danilo Pellin, Mariana Loperfido, Cristina Baricordi, Samuel L Wolock, Annita Montepeloso, Olga K Weinberg, Alessandra Biffi, Allon M Klein, Luca Biasco

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 228 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
228citing papers in PubMed, 1 pooled it
17.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

228 citing papers in PubMed, 1 synthesis or guideline pooled it, 369 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Evaluating the Utilities of Foundation Models in Single-Cell Data Analysis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Article

168 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Danilo PellinGene Therapy Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, 02115, USA.
Mariana LoperfidoGene Therapy Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, 02115, USA.ORCID http://orcid.org/0000-0001-9365-5388
Cristina BaricordiGene Therapy Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, 02115, USA.
Samuel L WolockDepartment of Systems Biology, Harvard Medical School, Boston, MA, 02115, USA.ORCID http://orcid.org/0000-0002-2120-4788
Annita MontepelosoGene Therapy Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, 02115, USA.
Olga K WeinbergDepartment of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA, 02115, USA.
Alessandra BiffiGene Therapy Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, 02115, USA.
Allon M KleinDepartment of Systems Biology, Harvard Medical School, Boston, MA, 02115, USA. Allon_Klein@hms.harvard.edu.ORCID http://orcid.org/0000-0001-8913-7879
Luca BiascoGene Therapy Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, 02115, USA. l.biasco@ucl.ac.uk.
Harvard University · USBoston Children's Hospital · USGreat Ormond Street Hospital · GB

Funding

Droplet microfluidic technology for single cell cancer genomicsR33CA212697 · NCI · HARVARD MEDICAL SCHOOL · PI KLEIN, ALLON MOSHE · 2017 to 2019
$1.3M
NCI NIH HHS R33 CA212697Wellcome Trust
6 · The paper itself

Abstract

Hematopoietic Stem/Progenitor cells (HSPCs) are endowed with the role of maintaining a diverse pool of blood cells throughout the human life. Despite recent efforts, the nature of the early cell fate decisions remains contentious. Using single-cell RNA-Seq, we show that existing approaches to stratify bone marrow CD34+ cells reveal a hierarchically-structured transcriptional landscape of hematopoietic differentiation. Still, this landscape misses important early fate decisions. We here provide a broader transcriptional profiling of bone marrow lineage negative hematopoietic progenitors that recovers a key missing branchpoint into basophils and expands our understanding of the underlying structure of early adult human haematopoiesis. We also show that this map has strong similarities in topology and gene expression to that found in mouse. Finally, we identify the sialomucin CD164, as a reliable marker for the earliest branches of HSPCs specification and we showed how its use can foster the design of alternative transplantation cell products.

Indexed as

AnimalsAntigens, CD34Bone Marrow CellsCell LineageEndolynGene Expression ProfilingHematopoiesisHematopoietic Stem CellsHumansMiceSequence Analysis, RNASingle-Cell AnalysisAntigens, CD34CD164 protein, humanEndolyn

Identifiers

PMID31160568
PMCPMC6546699
OpenAlexW2948104182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.